202
Views
13
CrossRef citations to date
0
Altmetric
Review

Sex differences in predictors of ischemic stroke: current perspectives

&
Pages 427-436 | Published online: 27 Jul 2015

Abstract

Globally, stroke is a significant public health concern affecting more than 33 million individuals. Of growing importance are the differences between males and females in the predictors and overall risk of stroke. Given that women have a higher lifetime risk for stoke and account for more than half of all stroke deaths, sex-specific stroke risk factors merit investigation and may help target public health interventions. This review aims to discuss the current body of knowledge regarding sex-specific predictors of ischemic stroke including both modifiable and non-modifiable risk factors, as well as specific pathologies known to increase stroke risk.

Introduction

Stroke affects 33 million individuals worldwide each year.Citation1 As of 2012, stroke was the third leading cause of death and the third leading cause of years of life lost due to premature mortality worldwide.Citation2 In the US, stroke is the fourth leading cause of death, accounting for 1 in 20 deaths, and is the leading cause of serious long-term disability. According to the Centers for Disease Control and Prevention, stroke accounted for 33% of potentially preventable deaths in the US between 2008 and 2010.Citation3 Nearly 87% of all strokes are ischemic.Citation1

Stroke in women is a growing public health concern. Stroke is the fourth leading cause of death in women ages 20–59 worldwide; by current estimates, women account for approximate 60% of all stroke deaths.Citation1,Citation4 In the >60 age group, stroke is the second leading cause of death among women. Recent research has also suggested that, among first-ever stroke patients, women are more frequently older, are more likely to have hypertension, atrial fibrillation (Afib), and cardioembolic infarction, and experience reduced mortality and length of hospitalization.Citation5

Among elderly stroke patients, 43% experienced moderate-to-severe neurological deficits post-stroke.Citation6 However, of these, women more frequently need assistance with activities of daily living and walking, and more often live in nursing homes after their stroke. Within the first 6 months after their stroke, women more often have disabilities of greater severity and extent than their male counterparts. In a subanalysis of the Framingham Heart Study, it was found that women were more disabled and 3.5 times as likely to be institutionalized at 3–6 months post-stroke compared with men.Citation7 Furthermore, the women in this cohort more frequently classified as a first-stroke event.

Compared with males, females have a higher lifetime risk for stroke, are more likely to experience recurrent stroke, and are more likely to have more severe strokes.Citation1 Patients with recurrent stroke are recognized to have as much as a 38% greater cost per patient-year after discharge from acute stroke hospitalization when compared with first-ever stroke patients.Citation1 As such, understanding the predictors of stroke unique to females is of significant import.

This article will explore differences in the risk among males and females posed by various predictors of stroke including non-modifiable risk factors, modifiable risk factors, and specific disease pathologies.

Non-modifiable risk factors

Sex differences in age

According to 2010 US Census Data, the 65+ age group accounts for 13% of the total US population; of these, 56.9% are female.Citation8 Nearly 75% of all strokes occur in individuals over 65 years old.Citation9 As of 2014, women worldwide have surpassed their male counterparts with respect to at-birth life expectancy by nearly 10 years on average.Citation6 In the US, the estimated at-birth life expectancy is 81.94 years for females compared with 79.56 years for males; after 65 years, life expectancy is 20.50 years for females and 17.90 years for males.Citation10 On average, women are about 4 years older than men at the time of their first stroke.Citation1

Overall, the incidence rate of stroke is 1.25 times higher in males compared with females and increases steadily with age for both males and females.Citation11 Given that a greater proportion of the population is female and females are likely to live longer, it logically follows that females account for nearly 60% of post-stroke mortality.Citation12

Recent research has also demonstrated that women are older at the time of their first stroke. Appelros et al found that, in 98 studies spanning 19 countries and 5 continents, the mean age of first-ever stroke is 72.9 years in women compared with 68.6 years in men.Citation13 Research has also shown that, due to longer lifespan, women have more strokes during their lifetime.Citation12

Sex differences in race

Differences are recognized in the prevalence of stroke between races. According to 2013 data from the Behavioral Risk Factor Surveillance System, American Indians/Alaska Natives exhibited the highest prevalence of history of stroke (4.6%), tied with other races/multiracial individuals.Citation1 Non-Hispanic blacks had the next highest prevalence (4.0%), followed by non-Hispanic whites (2.5%), Hispanics (2.3%), and Asian/Pacific Islanders (1.3%). Furthermore, between 2006 and 2010, individuals of black race had a higher prevalence of stroke compared with other races. Although the current evidence suggests a decline in the overall incidence of stroke among whites when comparing 2005 with earlier years, this decline has not been observed among blacks.

With respect to short-term outcomes following ischemic stroke, race and sex do not appear to significantly modify the relationship.Citation14 However, racial differences do exist in stroke mortality when stratified by sex. Compared with white men, black men experience a 1.4 times increased risk for stroke-related mortality.Citation15 Interestingly, black women experienced a twofold increased risk (risk ratio =2.0) when compared with white women. Some evidence also suggests that socioeconomic status may account for some of the risk attributed to stroke among black men; however, evidence for this relationship is limited.Citation16

Modifiable risk factors

Sex differences relating to hypertension

Approximately 77% of individuals who have an incident stroke have blood pressure greater than 140/90 mmHg.Citation17 The attributable risk for ischemic stroke due to hypertension is approximately 26%.Citation18 As of 2008, the prevalence of hypertension was approximately 40% in adults over 25 years of age, affecting 29.2% of males and 24.8% of females worldwide.Citation2 In the US, among adults ≥20 years old, the prevalence of hypertension varies by both race and sex as follows: among non-Hispanic whites, 33.4% for men and 30.7% for women; among non-Hispanic blacks, 42.6% for men and 47.0% for women; and among Mexican Americans, 30.1% for men and 28.8% for women.Citation17 In the <45 age group, more men than women have hypertension, in the 45–64 age group, the proportion of men and women with hypertension is approximately equal, and in the >64 age group, far more women than men have hypertension. Physical inactivity may be influencing this fluctuation in hypertension rates as women are more likely than men to be inactive in all age ranges (33.2% vs 29.9%).Citation19

Data from the National Health and Nutrition Examination Survey between 2007 and 2010 showed that, of individuals with high blood pressure in the US, approximately 47.5% do not have it controlled.Citation17 Furthermore, control rate among older women is lower than for older men.Citation19 It has been demonstrated that controlling blood pressure reduces the incidence of ischemic stroke.Citation20,Citation21 Additionally, lower rates of recurrent stroke have been associated with lower blood pressures.Citation1 In the US alone, the indirect and direct costs of hypertension were estimated to be more than $46 billion, suggesting that better management of hypertension could have a significant economic impact.Citation17

Sex differences relating to diabetes mellitus

Globally, in 2014, the prevalence of diabetes mellitus (DM) was 9% among adults over 18 years of age.Citation22 An estimated 347 million individuals have DM worldwide.Citation23 Of the 29.1 million individuals with DM in the US, approximately 8.1 million are undiagnosed.Citation24 More than 50% of individuals with DM will die from a cardiovascular-related cause.Citation22

The diabetic stroke patient is more likely to be younger, have hypertension, and have slower recovery time compared with non-diabetic patients.Citation25 Furthermore, stroke patients with diabetes are more likely to die as a result of the stroke. In those <55 years of age, the risk for stroke is ten times greater in diabetics compared with non-diabetics.Citation26 Women with DM are also at increased risk for stroke compared with their male counterparts, possibly due to the relationship between DM and atherosclerosis. In the Framingham study cohort, diabetic women had a 3.5 times higher risk for stroke compared with non-diabetic women, whereas diabetic men had a 2.1 times higher risk for stroke compared with non-diabetic men.Citation27

Sex differences relating to dyslipidemia

Total cholesterol

Regardless of sex, the relationship between total cholesterol and stroke remains unclear. Although the mechanism by which high cholesterol levels may lead to stroke is widely agreed upon, the current body of literature regarding cholesterol and ischemic stroke may be subject to bias. In many studies, both hemorrhagic and ischemic stroke were evaluated in tandem, thereby clouding the association.Citation28 Furthermore, many studies appear to frequently include fatal stroke as an endpoint, again leading to bias.Citation29 Overall, it appears that total cholesterol may have a cooperative effect with other factors that may contribute to the atherosclerotic process and, by extension, contribute to rates of ischemic stroke.

High-density lipoprotein

High-density lipoprotein (HDL) appears to have a direct association with ischemic stroke. Men and women have comparable HDL levels until puberty, but the level of HDL decreases significantly in men during adolescence to a normal adult level.Citation30 In women, there is a steady increase in HDL levels over time, possibly contributing to the later presentation of carotid disease.Citation31 Several studies have demonstrated increased rates of ischemic stroke among men with low levels of HDL, though that relationship has not yet been established among women.Citation28 In both men and women, every 1 mmol/L increase in HDL is associated with a 47% reduction in ischemic stroke.

Low-density lipoprotein

Evidence regarding the association between low-density lipoprotein (LDL) and ischemic stroke is limited. Overall, high LDL levels appear to correlate with thrombosis, particularly large vessel atherothrombosis.Citation32 In both men and women, it appears that elevated LDL confers a marginal increase in risk for ischemic stroke.Citation33

Triglycerides

The relationship between triglycerides and ischemic stroke remains a subject of debate. Some studies have suggested that high triglycerides are not related to an increased risk for ischemic stroke.Citation34 More recent research appears to contradict that theory. In 2008, the Copenhagen Heart Study found high triglyceride levels to be associated with increased risk for ischemic stroke in both men and women. However, in both the <55 and >55 age groups, the 10-year risk was greater in men than in women (2.6% and 16.7% vs 1.9% and 12.2%).Citation35 In 2011, Varbo et al corroborated these findings with their study results that suggested a stepwise relationship between triglyceride level and ischemic stroke risk.Citation36

Sex differences relating to smoking

In the US, more than 20% of adult males smoke compared with ~15% in adult females.Citation37 Interestingly, men tend to have higher quit rates compared with women, which further supports the modifiability of this risk factor.Citation38,Citation39 In both sexes, smoking is associated with an increased risk for stroke, and quitting is associated with a reduction of that risk.Citation40 Furthermore, women who smoke appear to have a greater overall disease risk associated with smoking compared with men, especially in relation to disease processes that may also lead to ischemic stroke.Citation40,Citation41 A meta-analysis demonstrated a dose response with regard to risk of stroke, higher risk associated with subarachnoid hemorrhage (relative risk [RR] 2.93) than ischemic stroke (RR 1.92), and overall greater risk in women (RR 1.72) compared with men (RR 1.43).Citation42

Sex differences relating to obstructive sleep apnea

Worldwide, the prevalence of obstructive sleep apnea (OSA) in adults is somewhere between 3% and 7% in the general population.Citation43 OSA is more common in men than in women. Newman et al described the incidence of OSA over a 5-year period to be about 11.1% in men and 4.9% in women.Citation44 However, the symptoms most commonly described by women with OSA are non-traditional, including insomnia and depression, which may mean that under-diagnosis exists among women.Citation45 Obesity, upper airway anatomy, sleep patterns and arousal, sex hormones – specifically changes associated with menopause, and respiratory control, are all associated with OSA and are modified by sex.

In both men and women, OSA is significantly associated with an increased risk for ischemic stroke and mortality.Citation46Citation48 Whether or not a difference exists between males and females in ischemic stroke risk is not well described in the literature and is worth future investigation.

Sex differences relating to substance abuse

Among women, the lifetime estimate is between 5% and 8% for alcohol-related disorders and between 5% and 6% for other drug-related disorders.Citation49 The alcohol and illicit drug use is more prevalent among men, but recent trends indicate that the prevalence of heavy alcohol use among women is approaching that of men. Alcohol has an unique effect that is observed across sexes: in light-to-moderate amounts, it appears to have either no effect or a protective effect relating to ischemic stroke risk; however, in excessive amounts, it has inconsistently been associated with increased risk for ischemic and hemorrhagic stroke.Citation50Citation52 Almost every commonly used drug type is associated with ischemic stroke including cocaine, amphetamine, opioids, cannabis, lysergic acid diethylamide, and anabolic steroids.Citation53 The illicit drug use is associated with about 14% of all ischemic and hemorrhagic strokes, stroke in young adults (<45 years old) and male sex.Citation49,Citation54 In a recent meta-analysis, the J-shaped relationship between ischemic stroke, hemorrhagic stroke, and even stroke mortality was confirmed.Citation55

Specific pathologies predicting ischemic stroke

Sex differences relating to large artery disease

Annually, severe carotid stenosis (>75%) is associated with a 3.3% rate of stroke and a 7.2% rate of transient ischemic attack.Citation56 Among adults age 33–45 years, the prevalence of carotid calcium is higher among males, irrespective of race.Citation1 This difference is consistent when examined across races in adults age 45–84 years. Male sex is associated with higher likelihood of detecting extracranial and combined intracranial and extracranial artery stenosis among patients admitted with first-ever ischemic stroke.Citation57,Citation58

In women, coronary disease generally present 10–15 years later than in men.Citation31 This may be due to sex differences in various risk factors for carotid artery disease. The Rotterdam Elderly Study determined that hypertension, smoking, and low levels of HDL are risk factors for developing carotid disease in the elderly population.Citation59 Each of these factors has also been independently linked as risk factors for ischemic stroke, as discussed earlier in this review.Citation60Citation62

For patients with carotid disease, revascularization through the use of stenting or endarterectomy is a current component of standard-of-care guidelines, when a patient meets the necessary criteria.Citation63 A subgroup analysis from the Carotid Revascularization Endarterectomy versus Stenting Trial revealed no difference between men and women in the rates of the primary endpoint defined as “the composite of any stroke, myocardial infarction, or death during the periprocedural period or ipsilateral stroke within 4 years after randomization”.Citation64 However, the risk for periprocedural stroke was higher in women in the stenting group; no such difference was detected in men. The American Heart Association/American Stroke Association (AHA/ASA) Guidelines for the Prevention of Stroke in Women advise that there is insufficient evidence to manage men and women differently with regard to choice of revascularization modality for symptomatic carotid stenosis.Citation65

Sex differences in small artery disease

The case-fatality rate of small vessel stroke (subcortical infarct <15 mm in diameter occluding a single perforating artery), sometimes referred to as a silent or lacunar infarct, is low at approximately 2.5% at 1 month.Citation66 A study conducted by Vermeer et al in an elderly population (60–90 years old) found a prevalence of radiographic small vessel stroke of 20% and an increase in the odds of small vessel stroke with age.Citation67 Furthermore, this study of persons of advanced age found a higher prevalence of small vessel stroke in women. Another study by Bejot et al that examined more than 2,000 ischemic stroke cases of all ages from 1989 to 2006 found a prevalence of 28% for small vessel stroke. The incidence of small vessel stroke increased steadily with age, but was overall higher in men than in women (18.3 vs 10.3 per 100,000 persons per year).Citation66 Interestingly, one study has found that in patients in the over 85-year category, small vessel stroke showed a significantly higher proportion of women.Citation68 Women with small vessel stroke tend to be older and more frequently have a history of obesity and hypertension as compared with men.Citation69

Small vessel disease is regarded as a leading cause of vascular-related cognitive impairment. By current estimates, 30% of patients who experience a small vessel stroke will have some cognitive impairment, ranging from mild cognitive impairment to dementia, in the 4 years post-stroke, regardless of sex.Citation70 No evidence of a sex modifier for vascular dementia exists, in contrast to female predominance of Alzheimer’s type of dementia.Citation71

Sex differences in predictors of cardioembolic stroke

Atrial fibrillation

Afib is a known risk factor for ischemic stroke.Citation1 The incidence of Afib in men is significantly higher (20.6 per 100,000 persons) compared with women (6.6 per 100,000 persons) in the 15–44 age range. However, in the >85 age group, the incidence of Afib is slightly higher in women (1,203.7 per 100,000 persons) than in men (1,077.4 per 100,000 persons). The prevalence of Afib is consistently higher in men than in women across age groups and races.

In the absence of valvular heart disease, the risk of stroke increases fivefold for individuals with Afib.Citation72 This increased risk may be due to the prothrombotic effect of endothelial dysfunction and inflammation resulting from Afib. Women appear to be at a greater risk for thromboembolism due to Afib than men when not on anticoagulation therapy (warfarin).Citation73 In fact, the efficacy of warfarin may be comparable, if not greater, in women as compared with men. However, a consensus has not yet been achieved regarding the risk for major bleeding while using warfarin, with some research suggesting equal rates between men and women, and others suggesting a greater risk in women.Citation73,Citation74 A recent meta-analysis supports improved efficacy of preventing stroke or systemic embolism coupled with lower risk of major bleeding in women compared with men who are treated with novel oral anticoagulants.Citation75

Heart failure

More than 23 million people have heart failure (HF) worldwide.Citation76 A subanalysis from the Framingham cohort found that the overall incidence of HF to be higher in men than in women (5.64 vs 3.27 per 1,000 person-years) with proportional increases with age for both sexes.Citation77 In women, HF tends to occur later and is more commonly associated with obesity, chronic kidney disease, Afib, hypertension, and preserved left ventricle (LV) ejection fraction.Citation78Citation81 In men, HF is associated with different comorbidities including anemia, myocardial infarction, chronic obstructive and pulmonary disease, and peripheral arteriopathy.Citation78 Overall, the risk of ischemic stroke is increased in the presence of reduced LV ejection fraction, irrespective of sex. However, a dose response (higher risk with moderate-to-severely reduced vs mildly reduced LV function) was detected only in men.Citation82

Sex differences in hormonal effects

Sex hormones

Research suggests that women experience a neuroprotective effect pre-menopause, likely relating to circulating ovarian hormones, particularly estrogen. Although the exact age ranges vary between studies, generally, women appear to experience a decreased risk for stroke between 40 and 75 years of age compared with men, but after 75, women experience around 50% greater risk for stroke than men.Citation83

Sex hormones play a significant role in reactivity of the cerebral vasculature.Citation84 In vivo, testosterone and estrogen appear to have opposing influences on reactivity of cerebral arteries, with estrogen having a vasodilation effect that may even counteract the effect of other serum vasoconstrictors. Other research has also identified that female arteries are generally less constricted possibly as a result of effect estrogen has on nitric oxide production in the endothelium.Citation85 Though not widely investigated in the literature, some researchers have hypothesized that, rather than estrogen lending a protective effect to women, perhaps males’ elevated risk is due to adverse effects of androgens.Citation31 The biochemical mechanisms relating to these sex hormones and the sex differences associated with them are beyond the scope of this article, but has been extensively detailed in a review by Krause et al.Citation84

Pre-menopausal women have the strongest cerebral reactivity when evaluated using transcranial Doppler ultrasonography.Citation86,Citation87 When matched with premenopausal women of the same age, postmenopausal women have significantly lower reactivity. However, when treated with hormone replacement therapy, the reactivity in postmenopausal women was similar to that of premenopausal women. Despite this response, several studies have demonstrated a lack of effect of hormone replacement therapy on reducing stroke incidence and mortality.Citation88Citation90 In fact, many studies have shown an increased incidence of ischemic stroke in addition to increased rates of both mortality and morbidity post-stroke.Citation1,Citation90 However, these findings contradict the protective effects seen in animal models and the biological effects seen in humans. Additionally, other studies have demonstrated a positive protective effect of hormone replacement against other coronary disease.Citation91,Citation92 Exogenous hormones may have different effects on stimulation of clotting factor formation than endogenous hormones. Currently, the body of research regarding hormone replacement therapy in relation to stroke has focused on primary and secondary prevention. Further research is warranted to determine the efficacy vs harm of hormone replacement as a treatment in acute ischemic stroke.

Oral contraceptives use

Premenopausal women, while inherently at decreased risk for ischemic stroke, may be at elevated risk if they use oral contraceptives (OC). The exact amount of increased risk attributed to the use of hormonal OC has been the subject of much debate. In the US, from 2006 to 2010, the Centers for Disease Control and Prevention reported that 82% of sexually ever-active women between 15 and 44 years of age used OC as a contraceptive method.Citation93 It is thought that estrogen/progestogen OC have a procoagulant effect by increasing the activity of various clotting factors within the coagulation cascade, including plasma fibrinogen, while decreasing the amount of anticoagulation factors.Citation94

Several studies have indicated elevated risk for venous thrombosis, myocardial infarction, and stroke in current OC users regardless of OC subtype.Citation95 In a meta-analysis of 16 studies by Gillum et al, current OC users were at 2.75 times increased risk for ischemic stroke.Citation96 Interestingly, the same study revealed a lower RR for ischemic stroke in estrogen doses <50 μg (2.08) compared with estrogen doses >50 μg (4.53). Furthermore, low-dose OC have been demonstrated to pose a 93% increased risk for ischemic stroke, though absolute increased risk is low at 4.1 ischemic strokes per 100,000 women.Citation1 However, those using lower-dose estrogen contraceptives still experienced elevated risk. Other case–control studies have corroborated these findings and have demonstrated an at least two times increased odds for ischemic stroke among OC users when compared with controls.Citation97,Citation98

Pregnancy

Pregnancy is an additional risk factor for ischemic stroke in women. Although the risk for stroke secondary to pregnancy has been explored, a consensus on the etiology of that risk or the level of increased risk has not yet been achieved. A literature review by Wiebers suggested as much as a 13-fold increase in the risk of ischemic stroke for pregnant women.Citation99 It has also been suggested that women’s risk is greatest during the postpartum period, though the exact reason for this is undetermined. Kittner et al reported that the RR for cerebral infarct during pregnancy was 0.7, but increased to 8.7 in the postpartum period.Citation100 Similarly, Jaigobin and Silver reported that a majority of women presented during the last trimester or postpartum.Citation101 With the exception of subarachnoid hemorrhage, the attributable excess risk of all types of stroke during the pregnancy/postpartum period was 8.1 per 100,000.Citation1 It has been suggested that this association may be due, at least in part, to the hormonal changes that occur during pregnancy. Clotting activity increases during pregnancy, possibly due to placental expulsion.Citation102,Citation103 It is hypothesized that the natural elevation of estradiol during pregnancy may cause increases in the activity levels of various plasma coagulation factors including factor VII and plasminogen activator inhibitor.Citation104 It has also been shown that levels of factors V, VIII, IX, X, XII, fibrinogen, and von Willebrand factor (vWF) all increase during pregnancy.Citation102 Elevated levels of these factors have been positively correlated with increased risk for stroke and may provide a linkage between pregnancy and increased stroke risk.Citation105Citation112

Sex differences in hypercoagulability

Hypercoagulability, particularly with respect to elevated Factor VIII (FVIII) and vWF, has recently been described as a potential risk factor for ischemic stroke. FVIII elevation has been shown to correlate to worse baseline stroke severity and an increased frequency of neuroworsening during the acute hospitalization.Citation106 Furthermore, combined elevation in FVIII and vWF appears to confer increased odds of poor functional outcome, inpatient complications, neuroworsening, and recurrent thrombotic events during acute hospitalization.Citation107 Among older patients, elevated FVIII appears to be associated with an increased risk for thrombosis and stroke in women.Citation113Citation117

Although FVIII has traditionally been viewed as an acute phase reactant, a recent study found that post-ischemic stroke, FVIII levels appear to remain elevated remote from index stroke in a majority of patients whose levels were elevated during the acute phase of ischemic stroke.Citation118 The study developed prediction models for determining which patients would experience persistently elevated FVIII at the two most commonly used activity thresholds, 150% and 200%. In both models, female sex was included as a predictor of persistent FVIII elevation. The correlation between elevated FVIII and the risk for ischemic stroke suggests that these persistently elevated levels may be a player in women’s propensity for multiple strokes. Additionally, the hormonal effects mentioned above may be related to the impact of hypercoagulability in women.

Conclusion

Men and women differ in their risk with respect to various predictors of ischemic stroke including age, carotid disease, hormonal changes, cardiac arrhythmias, and hypercoagulability. Further research is warranted in each of these areas to better understand the complexities of the effect of sex on ischemic stroke risk, etiology, and progression.

Disclosure

The authors report no conflicts of interest in this work.

References

  • MozaffarianDBenjaminEJGoASExecutive summary: heart disease and stroke statistics – 2015 update: a report from the American Heart AssociationCirculation20151314434441
  • World Health OrganizationWorld Health Statistics 2014GenevaWorld Health Organization2014
  • YoonPWBastianBAndersonRNCollinsJLJaffeHWPotentially preventable deaths from the five leading causes of death – United States, 2008–2010MMWR Morb Mortal Wkly Rep2014631736937424785982
  • World Health OrganizationWomen and Health: Today’s Evidence Tomorrow’s AgendaGenevaWorld Health Organization2009
  • ArboixACartanyàALowakMGender differences and woman-specific trends in acute stroke: results from a hospital-based registry (1986–2009)Clin Neurol Neurosurg2014127192425459238
  • Kelly-HayesMBeiserAKaseCSScaramucciAD’AgostinoRBWolfPAThe influence of gender and age on disability following ischemic stroke: the Framingham studyJ Stroke Cerebrovasc Dis200312311912617903915
  • PetreaREBeiserASSeshadriSKelly-HayesMKaseCSWolfPAGender differences in stroke incidence and poststroke disability in the Framingham heart studyStroke20094041032103719211484
  • HowdenLMMeyerJAAge and Sex Composition: 2010. 2010 Census BriefsWashington, DCUS Department of Commerce, Economics and Statistics Administration US Census Bureau2010
  • WestLA65+ in the United States: 2010Washington, DCUS Census Bureau2010
  • KochanekKDMurphySLXuJAriasEMortality in the United States, 2013NCHS Data Brief20141781824152376
  • MurphySJMcCulloughLDSmithJMStroke in the female: role of biological sex and estrogenILAR J200445214715915111734
  • WestLAColeSGoodkindDHeW65+ in the United States: 2010Washington, DCUS Census Bureau201423212
  • AppelrosPStegmayrBTeréntASex differences in stroke epidemiology a systematic reviewStroke20094041082109019211488
  • BoehmeAKSieglerJEMullenMTRacial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic strokeJ Stroke Cerebrovasc Dis2014234e255e26124468069
  • LotufoPAGoulartACBensenorIMRace, gender and stroke subtypes mortality in São Paulo, BrazilArq Neuropsiquiatr2007653B75275717952275
  • HowardGAndersonRTRussellGHowardVJBurkeGLRace, socioeconomic status, and cause-specific mortalityAnn Epidemiol200010421422310854956
  • American Heart AssociationHigh blood pressure – Statistical Fact Sheet 2014 UpdateDallas, TXAmerican Heart Association2015 Available from: http://www.heart.org/idc/groups/heart-public/@wcm/@sop/@smd/documents/downloadable/ucm_462020.pdfAccessed June 23, 2015
  • WhisnantJPModeling of risk factors for ischemic stroke. The Willis LectureStroke1997289184018449303034
  • DoumasMPapademetriouVFaselisCKokkinosPGender differences in hypertension: myths and realityCurr Hypertens Rep201315432133023749317
  • PsatyBMLumleyTFurbergCDHealth outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysisJAMA2003289192534254412759325
  • ChobanianAVBakrisGLBlackHRThe seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 reportJAMA2003289192560257112748199
  • World Health OrganizationDiabetes Fact SheetMedia CentreGenevaWorld Health Organization2015
  • World Health Organization10 Facts About Diabetes Available from: http://www.who.int/features/factfiles/diabetes/en/Accessed April 1, 2015
  • Centers for Disease Control and PreventionNational Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States, 2014Atlanta, GAUS Department of Health and Human Services2014
  • JørgensenHNakayamaHRaaschouHOOlsenTSStroke in patients with diabetes. The Copenhagen Stroke StudyStroke19942510197719848091441
  • BeckmanJACreagerMALibbyPDiabetes and atherosclerosis: epidemiology, pathophysiology, and managementJAMA2002287192570258112020339
  • FranconiFCampesiIOcchioniSTonoloGSex-gender differences in diabetes vascular complications and treatmentEndocr Metab Immune Disord Drug Targets201212217919622236023
  • GoldsteinLBAdamsRAlbertsMJAHA/ASA guidelineCirculation2006113e873e92316785347
  • ThriftAGCholesterol is associated with stroke, but is not a risk factorStroke20043561524152515105510
  • KirklandRTKeenanBSProbstfieldJLDecrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence: correlation with plasma testosterone levelsJAMA198725745025073098992
  • RossouwJEHormones, genetic factors, and gender differences in cardiovascular diseaseCardiovasc Res200253355055711861025
  • Koren-MoragNTanneDGraffEGoldbourtULow-and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registryArch Intern Med2002162999399911996608
  • ShaharEChamblessLERosamondWDPlasma lipid profile and incident ischemic stroke the atherosclerosis risk in communities (ARIC) studyStroke200334362363112624282
  • BowmanTSSessoHDMaJCholesterol and the risk of ischemic strokeStroke200334122930293414615618
  • FreibergJJTybjærg-HansenAJensenJSNordestgaardBGNonfasting triglycerides and risk of ischemic stroke in the general populationJAMA2008300182142215219001625
  • VarboANordestgaardBGTybjærg-HansenASchnohrPJensenGBBennMNonfasting triglycerides, cholesterol, and ischemic stroke in the general populationAnn Neurol201169462863421337605
  • JamalAAgakuITO’ConnorEKingBAKenemerJBNeffLCurrent cigarette smoking among adults – United States, 2005–2013MMWR Morb Mortal Wkly Rep201463471108111225426653
  • BjornsonWRandCConnettJEGender differences in smoking cessation after 3 years in the Lung Health StudyAm J Public Health19958522232307856782
  • WetterDWKenfordSLSmithSSFioreMCJorenbyDEBakerTBGender differences in smoking cessationJ Consult Clin Psychol199967455510450626
  • PetersSAEHuxleyRRWoodwardMSmoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokesStroke201344102821282823970792
  • MuchaLStephensonJMorandiNDiraniRMeta-analysis of disease risk associated with smoking, by gender and intensity of smokingGender Med200634279291
  • ShintonRBeeversGMeta-analysis of relation between cigarette smoking and strokeBMJ198929866767897942496858
  • PunjabiNMThe epidemiology of adult obstructive sleep apneaProc Am Thorac Soc20085213614318250205
  • NewmanABFosterGGivelberRNietoFJRedlineSYoungTProgression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health StudyArch Intern Med2005165202408241316287771
  • LinCMDavidsonTMAncoli-IsraelSGender differences in obstructive sleep apnea and treatment implicationsSleep Med Rev200812648149618951050
  • YaggiHKConcatoJKernanWNLichtmanJHBrassLMMohseninVObstructive sleep apnea as a risk factor for stroke and deathN Engl J Med2005353192034204116282178
  • SahlinCSandbergOGustafsonYObstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-upArch Intern Med2008168329730118268171
  • Campos-RodriguezFMartinez-GarciaMAReyes-NuñezNCaballero-MartinezICatalan-SerraPAlmeida-GonzalezCVRole of sleep apnea and continuous positive airway pressure therapy in the incidence of stroke or coronary heart disease in womenAm J Respir Crit Care Med2014189121544155024673616
  • ZilbermanMTavaresHEl-GuebalyNGender similarities and differences: the prevalence and course of alcohol and other substance – related disordersJ Addict Dis2004224617414723478
  • ReynoldsKLewisBNolenJDLKinneyGLSathyaBHeJAlcohol consumption and risk of stroke: a meta-analysisJAMA2003289557958812578491
  • JimenezMChiuveSEGlynnRJAlcohol consumption and risk of stroke in womenStroke201243493994522403048
  • DjousséLEllisonRCBeiserAScaramucciAD’AgostinoRBWolfPAAlcohol consumption and risk of ischemic stroke: the Framingham StudyStroke200233490791211935035
  • FonsecaACFerroJMDrug abuse and strokeCurr Neurol Neurosci Rep201313219
  • EsseKFossati-BellaniMTraylorAMartin-SchildSEpidemic of illicit drug use, mechanisms of action/addiction and stroke as a health hazardBrain Behav201111445422398980
  • ZhangCQinY-YChenQAlcohol intake and risk of stroke: a dose–response meta-analysis of prospective studiesInt J Cardiol2014174366967724820756
  • NorrisJWZhuCZBornsteinNMChambersBRVascular risks of asymptomatic carotid stenosisStroke19912212148514901962321
  • LeiCWuBLiuMChenYRisk factors and clinical outcomes associated with intracranial and extracranial atherosclerotic stenosis acute ischemic strokeJ Stroke Cerebrovasc Dis20142351112111724189455
  • de WeerdMGrevingJPde JongAWFBuskensEBotsMLPrevalence of asymptomatic carotid artery stenosis according to age and sex systematic review and metaregression analysisStroke20094041105111319246704
  • BotsMLBreslauPJBriëtECardiovascular determinants of carotid artery disease. The Rotterdam Elderly StudyHypertension1992196 Pt 27177201592472
  • DemarinVLisakMMorovićSČengićTLow high-density lipoprotein cholesterol as the possible risk factor for strokeActa Clin Croat201049442943921830454
  • WolfPAD’AgostinoRBKannelWBBonitaRBelangerAJCigarette smoking as a risk factor for stroke: the Framingham StudyJAMA19882597102510293339799
  • MacMahonSPetoRCollinsRBlood pressure, stroke, and coronary heart disease: part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasLancet199033586927657741969518
  • BrottTGHalperinJLAbbaraS2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed TomographyJ Am Coll Cardiol2011578e16e9421288679
  • HowardVJLutsepHLMackeyAInfluence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST)Lancet Neurol201110653053721550314
  • BushnellCMcCulloughLDAwadIAGuidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke AssociationStroke20144551545158824503673
  • BejotYCatteauACaillierMTrends in incidence, risk factors, and survival in symptomatic lacunar stroke in Dijon, France, from 1989 to 2006: a population-based studyStroke20083971945195118436869
  • VermeerSEKoudstaalPJOudkerkMHofmanABretelerMMBPrevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan StudyStroke2002331212511779883
  • ArboixAGarcía-ErolesLMassonsJOliveresMTargaCLacunar infarcts in patients aged 85 years and olderActa Neurol Scand20001011252910660148
  • ArboixABlanco-RojasLOliveresMGarcía-ErolesLComesEMassonsJClinical characteristics of acute lacunar stroke in women: emphasis on gender differencesActa Neurol Belg2014114210711224194419
  • MakinSDJTurpinSDennisMSWardlawJMCognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypesJ Neurol Neurosurg Psychiatry201384889390023457225
  • AndersenKLaunerLJDeweyMEGender differences in the incidence of AD and vascular dementia: The EURODEM StudiesNeurology19995391992199710599770
  • LimHSWilloughbySRSchultzCEffect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythmJ Am Coll Cardiol201361885286023333141
  • FangMCSingerDEChangYGender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation the AnTicoagulation and Risk factors in Atrial fibrillation (ATRIA) studyCirculation2005112121687169116157766
  • HumphriesKHKerrCRConnollySJNew-onset atrial fibrillation sex differences in presentation, treatment, and outcomeCirculation2001103192365237011352885
  • PancholySBSharmaPSPancholyDSPatelTMCallansDJMarchlinskiFEMeta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulantsAm J Cardiol2014113348549024315113
  • BuiALHorwichTBFonarowGCEpidemiology and risk profile of heart failureNat Rev Cardiol201181304121060326
  • LevyDKenchaiahSLarsonMGLong-term trends in the incidence of and survival with heart failureN Engl J Med2002347181397140212409541
  • Conde-MartelAArkuchMEFormigaFGender related differences in clinical profile and outcome of patients with heart failure. Results of the RICA RegistryRev Clin Esp Epub3182015
  • ButlerJKalogeropoulosAPGeorgiopoulouVVSystolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition StudyHeart201197161304131121636845
  • Regitz-ZagrosekVBrokatSTschopeCRole of gender in heart failure with normal left ventricular ejection fractionProg Cardiovasc Dis200749424125117185112
  • MasoudiFAHavranekEPSmithGGender, age, and heart failure with preserved left ventricular systolic functionJ Am Coll Cardiol200341221722312535812
  • HaysAGSaccoRLRundekTLeft ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic populationStroke20063771715171916741172
  • ReevesMJBushnellCDHowardGSex differences in stroke: epidemiology, clinical presentation, medical care, and outcomesLancet Neurol200871091592618722812
  • KrauseDNDucklesSPPelligrinoDAInfluence of sex steroid hormones on cerebrovascular functionJ Appl Physiol200610141252126116794020
  • GearyGGKrauseDNDucklesSPEstrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteriesAm J Physiol Heart Circ Physiol19982751H292H300
  • MatteisMTroisiEMonaldoBCCaltagironeCSilvestriniMAge and sex differences in cerebral hemodynamics a transcranial Doppler studyStroke19982959639679596243
  • ViscoliCMBrassLMKernanWNSarrelPMSuissaSHorwitzRIA clinical trial of estrogen-replacement therapy after ischemic strokeN Engl J Med2001345171243124911680444
  • HulleySGradyDBushTRandomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal womenJAMA199828076056139718051
  • Wassertheil-SmollerSHendrixSLimacherMEffect of estrogen plus progestin on stroke in postmenopausal women: the Women’s Health Initiative: a randomized trialJAMA2003289202673268412771114
  • BilleciAMRPaciaroniMCasoVAgnelliGHormone replacement therapy and strokeCurr Vasc Pharmacol20086211212318393913
  • GradyDRubinSMPetittiDBHormone therapy to prevent disease and prolong life in postmenopausal womenAnn Intern Med199211712101610371443971
  • WhittingtonRFauldsDHormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart diseasePharmacoeconomics19945651355410147266
  • DanielsKMosherWDJonesJContraceptive methods women have ever used: United States, 1982–2010Natl Health Stat Rep201362202013
  • BonnarJCoagulation effects of oral contraceptionAm J Obst Gynecol19871574104210482960241
  • VesseyMMantDSmithAYeatesDOral contraceptives and venous thromboembolism: findings in a large prospective studyBr Med J (Clin Res Ed)19862926519526
  • GillumLAMamidipudiSKJohnstonSCIschemic stroke risk with oral contraceptives: a meta-analysisJAMA20002841727810872016
  • RyanKAColeJWSaslowKPrevention opportunities for oral contraceptive–associated ischemic strokeStroke201445389389524448988
  • KemmerenJMTanisBCvan den BoschMARisk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study: oral contraceptives and the risk of ischemic strokeStroke20023351202120811988591
  • WiebersDOIschemic cerebrovascular complications of pregnancyArch Neurol1985411110611132864911
  • KittnerSJSternBJFeeserBRPregnancy and the risk of strokeN Engl J Med1996335117687748703181
  • JaigobinCSilverFLStroke and pregnancyStroke200031122948295111108754
  • BremmeKAHaemostatic changes in pregnancyBest Pract Res Clin Haematol200316215316812763484
  • GilabertJAznarJParrillaJJReganonEVilaVEstellesAAlterations in the coagulation and fibrinolysis system in pregnancy, labour and puerperium, with special reference to a possible transitory state of intravascular coagulation during labourThromb Haemost1978402387396104402
  • SattarNGreerIARumleyAA longitudinal study of the relationships between haemostatic, lipid, and oestradiol changes during normal human pregnancyThromb Haemost199981171759974378
  • ZakaiNALangeLLongstrethWTAssociation of coagulation-related and inflammation-related genes and factor VIIc levels with stroke: the Cardiovascular Health StudyJ Thromb Haemost20119226727421114618
  • ChangTRAlbrightKCBoehmeAKFactor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable stateClin Appl Thromb Hemost201420212412823677913
  • SamaiAMonlezunDShabanAVon Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic strokeStroke20144592789279125028444
  • BiswasARanjanRMeenaAProthrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian IndiansThromb Res2009124439740219560187
  • HeikalNMMurphyKKCristRAWilsonARRodgersGMSmockKJElevated Factor IX activity is associated with an increased odds ratio for both arterial and venous thrombotic eventsAm J Clin Pathol2013140568068524124147
  • BiasiuttiFDBergerDMattleHPLämmleBWuilleminWAHemostatic risk factors in ischemic strokeThromb Haemost20039061094109914652642
  • SuriMFKYamagishiKAleksicNHannanPJFolsomARNovel hemostatic factor levels and risk of ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) StudyCerebrovasc Dis201029549750220299790
  • MishraMNKalraRRohatgiSClinical profile, common thrombophilia markers and risk factors in 85 young Indian patients with arterial thrombosisSao Paulo Med J2013131638438824346777
  • CattoAJCarterAMBarrettJHBamfordJRicePJGrantPJVon Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortalityThromb Haemost1997776110411089241740
  • BankILibourelEJMiddeldorpSElevated levels of FVIII: C within families are associated with an increased risk for venous and arterial thrombosisJ Thromb Haemost200531798415634269
  • JeremicMWeisertOGedde-DahlTWFactor VIII (AHG) levels in 1016 regular blood donors: the effects of age, sex, and ABO blood groupsScand J Clin Lab Invest1976365461466981956
  • ConlanMGFolsomARFinchAAssociations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) StudyThromb Haemost19937033803858259533
  • SieglerJESamaiAAlbrightKCBoehmeAKMartin-SchildSFactoring in Factor VIII with acute ischemic strokeClin Appl Thromb Hemost Epub2102015
  • SamaiAABoehmeAKShabanAAbstract T P190: a model for predicting persistent elevation of factor VIII among patients with Acute Ischemic Stroke (AIS)Stroke201546Suppl 1ATP190